The Nelson Report

As freight fraud costs the industry billions, Highway's new partner program aims to build a collective shield by embedding identity verification across the ecosystem.

Digital asset firm ReserveOne moves closer to a public debut via a SPAC deal, testing the waters for crypto companies in a shifting regulatory climate.

As deepfakes and synthetic identities surge, Aware, Inc. earns critical third-party certifications, proving its tech is secure, fair, and ready for reality.

A new report reveals chronic underfunding and human error leave U.S. public services dangerously exposed to relentless ransomware and phishing attacks.

New research reveals a swift move to AI in accounting, but professionals insist on one condition: technology will assist, not replace, human oversight.

How did a Tennessee 3PL achieve 18x shipment growth? A deep dive into the unified tech platform and AI strategy that’s rewriting the rules of freight.

Bosnia and Herzegovina's top operator is overhauling its core tech for the 5G era, partnering with Qvantel for a modern, cloud-native platform.

With a bolstered cash runway from recent funding, Inventiva is all-in on its MASH drug, lanifibranor, racing against giants in a multi-billion dollar market.

Armada Hoffler rebrands as AH Realty Trust, divesting multifamily and construction assets to slash debt and double down on the retail and office sectors.

Virtual IT Group appoints ex-Optus leader Maurice McCarthy as CEO, signaling a strategic push to secure the mid-market amid rising cyber and AI pressures.

Cement giant Vicat posts solid 2025 results, navigating market volatility with a green strategy and securing major funding for its VAIA carbon capture project.

A SPAC merger aims to list a key rare earths player on Nasdaq, fueling Europe's quest for mineral independence from China. Here is what's at stake.

The global market for smart gates is set to surge, driven by AI, biometrics, and security fears. But can we balance safety with personal privacy?

A landmark trial for Roche’s Gazyva shows unprecedented success in treating primary membranous nephropathy, offering hope of preventing kidney failure.

With a new interim CEO and mounting financial pressure, VERSES AI's upcoming investor webinar is a pivotal test of its bio-inspired AI vision.

After its lead anxiety drug failed a key trial, Vistagen turns to AI and a new menopause treatment to secure its future. Can the company recover?

A jury verdict against Olin Corporation in a contract dispute with Shintech will cost the chemical giant $185 million and raises industry-wide questions.

From soil sensing to autonomous robots, see how five new startups are helping John Deere redefine the future of agriculture and construction.

A swift $34.3M bridge loan from Greystone preserves critical affordable housing in Raleigh, a city grappling with rapid growth and soaring housing costs.

A Canadian-made prostate treatment wins a major innovation award as new U.S. Medicare reimbursement positions it for explosive market growth.